ERT-GFAN:一种基于分子生物学和知识增强的注意力机制的多式药物向相互作用预测模型
Xiaoqing Cheng1, Xixin Yang2, Yuanlin Guan3
1College of Computer Science and Technology, Qingdao University, Qingdao, 266071, China.
Computers in biology and medicine
|August 17, 2024
概括
ERT-GFAN是一种新的多式模式,通过整合结构,相互作用和上下文特征来增强药物向相互作用预测. 这种方法显著提高了药物发现和理解药物机制的准确性.
科学领域:
- 计算生物学 计算生物学
- 生物信息学是一种生物信息学.
- 药物发现 药物发现 药物发现
背景情况:
- 准确的药物向相互作用 (DTI) 识别对于新药开发和机制理解至关重要.
- 不同类型的药物和目标数据在DTI预测中对多式联络表示提出了挑战.
- 现有的方法很难有效地整合各种数据类型,以进行可靠的DTI预测.
研究的目的:
- 开发一种多模式药物向相互作用预测模型,ERT-GFAN,利用生物灵感原则和先进的机器学习技术.
- 解决当前DTI预测模型在处理复杂和异质数据方面的局限性.
- 通过多式联运特征融合,提高DTI预测的准确性和稳定性.
主要方法:
- 利用扩展连接指纹 (ECFP) 进行生物灵感药物和目标结构特征提取.
- 采用RotatE知识图嵌入模型来捕捉药物向相互作用特征.
- 集成式变压器网络用于改进上下文邻里特征和构建多式联运高维融合特征.
- 开发了一个图形高维融合特征注意网络 (GFAN) 用于最终的DTI预测.
主要成果:
- 在三个数据集上,ERT-GFAN实现了卓越的性能,AUC高 (高达0.9862),AUPR高 (高达0.9789),MRR高 (高达0.7386).
- 与单模和双模基线模型相比,废除研究表明预测性能有超过5%的改善.
- 该模型有效地整合了结构,交互和上下文邻里特征,用于全面的DTI预测.
结论:
- ERT-GFAN提供了一种强大而有效的多式联络方法,用于药物向相互作用的预测.
- 该模型成功地解决了复杂的知识图和异质数据所带来的挑战.
- 这些发现突显了ERT-GFAN在促进药物发现和理解药物机制方面的潜力.
相关概念视频
G Protein-coupled Receptors
11.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.6K
Transducer Mechanism: G Protein–Coupled Receptors
1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.9K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K


